Ertugliflozin L-pyroglutamic acid Chemical Properties

storage temp. 

under inert gas (nitrogen or Argon) at 2-8°C

solubility 

DMSO: ≥ 125 mg/mL (220.85 mM)

form 

Solid

color 

White to off-white

InChI

InChI=1/C22H25ClO7.C5H7NO3/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22;7-4-2-1-3(6-4)5(8)9/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3;3H,1-2H2,(H,6,7)(H,8,9)/t18-,19-,20+,21-,22-;3-/s3

InChIKey

YHIUPZFKHZTLSH-NCRAORDPNA-N

SMILES

C([C@@H]1CCC(=O)N1)(=O)O.O[C@@H]1[C@H]([C@H](O)[C@]2(CO)CO[C@@]1(C1C=CC(Cl)=C(CC3C=CC(OCC)=CC=3)C=1)O2)O |&1:1,10,11,12,14,19,r|

Ertugliflozin L-pyroglutamic acid Usage And Synthesis

Description

Ertugliflozin L-pyroglutamic acid is a potent, selective, orally active sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor with an IC50 value of 0.877 nM for h-SGLT2.It is the main active ingredient in the tablet ertugliflozin. It is the main active ingredient of ertugliflozin tablets. It is used as an adjunctive therapy for type 2 diabetes.

Chemical Properties

Ertugliflozin L-pyroglutamic acid is a white to off-white powder, soluble in ethanol and acetone, slightly soluble in ethyl acetate and acetonitrile, and very slightly soluble in water.

Uses

Ertugliflozin L-pyroglutamic Acid is a reagent in the synthesis of Ertugliflozin (1210344-57-2) a sodium/glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes.

brand name

STEGLATRO

Ertugliflozin L-pyroglutamic acid(1210344-83-4)Related Product Information

• Reboxetine
• ReMogliflozin etabonate
• TOFOGLIFLOZIN
• Dapagliflozin
• SERGLIFLOZIN
• Empagliflozin
• D-Glucitol, 1,5-dideoxy-1,5-epithio-1-C-[5-[(4-ethoxyphenyl)Methyl]-2-Methoxy-4-Methylphenyl]-, (1S)-
• Tofogliflozin
• 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
• Acetoxy Empagliflozin
• Canagliflozin